The aim of the study was to assess the effectiveness and safety of different doses of the treatment in adults with moderate to severe atopic eczema.
发布者:BY CHRISTOPHER DUE KARLSSON,转转请注明出处:https://robotalks.cn/leo-pharma-achieves-positive-results-with-antibody-therapy-in-phase-2b-trial/